In patients with heart failure, a previous study19 reported that compared to BNP, the first-line biomarker in the prognosis of this disease, the BDNF was similarly effective in predicting adverse events in this population (AUC 0.827 and 0.798, respectively). Here, NPPB is linked to heart failure.